Skip to main content
Clinical Trials/IRCT20200208046412N1
IRCT20200208046412N1
Completed
Phase 3

Evaluating the effect of bowel preparation plus oral Rifaximin on Rectum volume and Dosimetric Parameters in intravaginal High-Dose-Rate Brachytherapy for endometrial and cervical Cancer

Ahvaz University of Medical Sciences0 sites24 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
24
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • pathology based endometrial and cervical cancer
  • doing surgical treatment before brachytherapy
  • correct cylinder insertion

Exclusion Criteria

  • no surgery before brachyhterapy treatment
  • weight above 100 killogram causing not to do MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials